Israel21c reports that a study by London-based Aging Analytics Agency says that Israel is a global leader on healthy aging research.
Citing Israel’s “highly mature academic geroscience landscape,” the report states: “For a number of years, Israel has outputted high-volume, high-quality research into the fundamental biology of aging and potential healthspan extension interventions.”
The report, one of a series of regional case studies of the longevity industry, points out that all seven Israeli universities have, or will soon have, labs or interdisciplinary centers dedicated to aging research.
“This has happened nowhere else in the world and should be applauded,” says Eric Kihlstrom, director of the Aging Analytics Agency.
Three of the most prominent Israeli researchers listed are Valery Krizhanovsky of the Weizmann Institute, whose lab studies how senescent (deteriorating) cells affect cancer, aging and age-related diseases; Haim Cohen, head of the Molecular Mechanism of Aging Lab at Bar-Ilan University; and Michal Schwartz, also of the Weizmann Institute, whose lab created the groundwork to develop immunotherapy for Alzheimer’s disease.